Seaport Therapeutics, Inc.

Seaport Therapeutics (SPTX) has recorded no cyber incidents or red-flag 8-K filings in the past 90 days, suggesting a stable near-term operational backdrop. However, the absence of recent events does not eliminate structural risks; many biotech firms face dilution pressures and financing volatility that emerge over longer periods. The full $49 Report extends the timeline to 12 months, layers in dilution risk scoring and financing history context, and flags AI-detected signals that may not yet appear in standard filings. This deeper view transforms a clean recent snapshot into a forward-looking risk profile.